CU23150A3 - MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE - Google Patents

MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE

Info

Publication number
CU23150A3
CU23150A3 CU20000065A CU20000065A CU23150A3 CU 23150 A3 CU23150 A3 CU 23150A3 CU 20000065 A CU20000065 A CU 20000065A CU 20000065 A CU20000065 A CU 20000065A CU 23150 A3 CU23150 A3 CU 23150A3
Authority
CU
Cuba
Prior art keywords
active substance
controlled release
medicinal formulation
release
medicinal
Prior art date
Application number
CU20000065A
Other languages
Spanish (es)
Inventor
Tobias Laich
Stefan Kettelhoit
Heino Stass
Patrick Bosche
Hans-Martin Siefert
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to CU20000065A priority Critical patent/CU23150A3/en
Publication of CU23150A3 publication Critical patent/CU23150A3/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se refiere a formulaciones de medicamento que comprenden como sustancia activa Acido 1-ciclopropil-7-( [S,S]-2,8-diazabiciclo [4.3.0] non-8-il)-6-fluor-1,4-dihidro-8-metoxi-4oxo-3-quinolocarboxílico y/o sales farmacÉuticamente aceptables de este y/o hidratos de este, que liberen la sustancia activa que contienen con una liberacion definida.The invention relates to medicament formulations comprising as active substance Acid 1-cyclopropyl-7- ([S, S] -2,8-diazabicyclo [4.3.0] non-8-yl) -6-fluor-1, 4-dihydro-8-methoxy-4oxo-3-quinolocarboxylic and / or pharmaceutically acceptable salts thereof and / or hydrates thereof, which release the active substance they contain with a defined release.

CU20000065A 2000-03-24 2000-03-24 MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE CU23150A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20000065A CU23150A3 (en) 2000-03-24 2000-03-24 MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20000065A CU23150A3 (en) 2000-03-24 2000-03-24 MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE

Publications (1)

Publication Number Publication Date
CU23150A3 true CU23150A3 (en) 2006-06-29

Family

ID=40091552

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20000065A CU23150A3 (en) 2000-03-24 2000-03-24 MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE

Country Status (1)

Country Link
CU (1) CU23150A3 (en)

Similar Documents

Publication Publication Date Title
DE122011100049I1 (en) Stable pharmaceutical solution formulations for pressurized inhalers for the administration of metered doses.
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
ATE309798T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES
SV2004001418A (en) PHARMACEUTICAL FORMULATIONS OF 5,7,14-TRIAZACICLO 10.3.1.0.2,11.04,9) -HEXADECA-2 (11), 3,5,7,9-PENTAENO "REF.PC 23248
UY26372A1 (en) "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM"
UY25192A1 (en) DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE
AR023972A1 (en) COMPOSITIONS OF MEDICINES BASED ON ANTI-POLINERGICALLY ACTIVE AND BETA-MIMETIC COMPOUNDS
PA8575701A1 (en) ACID INSULIN PREPARATIONS WITH IMPROVED STABILITY
CR7362A (en) PHARMACEUTICAL FORMULATIONS OF PLATINUM DERIVATIVE
BR0114799A (en) Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents
AR032293A1 (en) PHARMACEUTICAL CASE
AU2108500A (en) Galenic formulation containing biotin
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
ATE291421T1 (en) PHARMACEUTICAL EFFORTABLE FORMULATION CONTAINING RAMIPRIL
CU23150A3 (en) MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE
SV2002000112A (en) PHARMACEUTICAL COMPLEX REF.PCS10331AKSR / BB
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
HN1999000174A (en) ACUISA MEDICATION FORMULATION FOR ORAL ADMINISTRATION.
ATE258046T1 (en) PHARMACEUTICAL EFFORTABLE FORMULATION CONTAINING METAMIZOLE
ECSP982679A (en) DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them